Released on = May 14, 2007, 6:57 am

Press Release Author = Synergy Research Group

Industry = Healthcare

Press Release Summary = On April 25, 2007, the first issue of the Orange Paper - the
first analytical review on market of clinical trials in Russia - was officially
presented. The strategic goals of Synergy Research Group, a Russia-based emerging
CRO, are formation of a civilized market of clinical trials in Russia, raising the
country's research attractiveness for foreign sponsors, and exoneration of clinical
trials in Russian public opinion.

Press Release Body = On April 25, 2007, the first issue of the Orange Paper - the
first analytical review on market of clinical trials in Russia - was officially
presented. The strategic goals of Synergy Research Group, a Russia-based emerging
CRO, are formation of a civilized market of clinical trials in Russia, raising the
country's research attractiveness for foreign sponsors, and exoneration of clinical
trials in Russian public opinion.

The Orange Paper - a series of regular reviews of the Russian market of clinical
trials - will be the first step in this direction. The reports will be published in
Russia both in the electronic and hard-copy form. While the English-language version
will be distributed abroad by subscription and on popular websites dedicated to
clinical trials, the hard-copy edition is to be distributed at international
exhibitions and conferences on clinical trials.

The first issue presents the general overview of the Russian market of clinical
trials as for the beginning of 2007. The quarterly publications to follow will
elaborate in a more detailed way the subjects tackled in the review: general
possibility of conducting clinical trials in Russia, review of the current
legislative base, analysis of clinical trials being held in Russia today (by their
sponsors, stages and therapeutic fields), rating of the most active foreign and
Russian medication developers, review of services and rating of contract research
organizations operating in Russia, review of research centers, laboratories,
facilities for storage of samples, and other service suppliers for holding clinical
trials in Russia.

According to Nikolay Odintsov, the Director General of Synergy Research Group, "the
document opens a series of publications meant to provide all the concerned people
with objective and unbiased, and (which is the most important) fresh and up-to-date
information on the market of clinical trials in Russia".

Synergy Research Group (SynRGT) is a Russian contract research organization, which
has been successfully operating all over Russia and the CIS member-states since
2002. SynRGT offers a broad range of services for conducting clinical trials for
Russian and foreign pharmaceutical and biotechnological companies - from
registration of the studies in regulatory authorities to pharmaco-economic surveys.
The company has its own storehouse of clinical samples in Moscow, with the total
area of 180 square meters. Today, Synergy Research Group is represented in Moscow,
Saint-Petersburg, Novosibirsk, Yekaterinburg and Almaty. The company's headquarters
are in Moscow.


Web Site = http://www.synrg-pharm.com/en/article11.htm

Contact Details = 14, Presnensky Val, 123557 Moscow, Russia
E-mail: office@synrg-pharm.com